The Food and Drug Administration (FDA) approved Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs), a subcutaneous injection, for all previously approved indications of the intravenous ...

Patients receiving subcutaneous daratumumab have less chair time and premedication than those receiving IV formulation, says ...

Preparation Site selection Recommended sites for subcutaneous injection include the lateral aspects of the upper arm and thigh, and the umbilical region of the abdomen (Ogston-Tuck, 2014; Hunter, 2008 ...

There was a recent epidemic of unexplained illness and death among injection drug users in Scotland, Ireland and England. The syndrome-based case definition was soft-tissue inflammation (abscess, ...

MISSISSAUGA, ON, May 8, 2014 /CNW/ - Roche today announced that Health Canada has approved a subcutaneous (SC) formulation of ACTEMRA (tocilizumab) for the treatment of adults with moderately to ...